- Title:
- Clinical efficacy and molecular biomarkers in a phase II study of tucidinostat plus R-CHOP in elderly patients with newly diagnosed diffuse large B-cell lymphoma
- Authors:
- Source:
- Clinical Epigenetics. 12(1)
- Academic Journal
Dear user, the application need JavaScript support. Please enable JavaScript in your browser.